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I. EXTENDED ABSTRACT
Pathogenic single nucleotide variants (SNV) can affect
binding affinity or change the specificity of a protein-protein
interaction (PPI). It is a known fact that modulating PPIs with
small molecules is a long sought strategy in drug discovery. We
face three major problems: i) the lack of available structures
for the majority of PPIs in human; ii) the absence of natural
cavities in protein-protein interfaces that could be used to iden-
tify small molecules as in standard enzyme inhibitor discovery;
and iii) how a small molecule can compete with a large protein
interface. We have developed a strategy for identifying small
molecule inhibitors of PPIs when complex structure is not
available, based on the integration of molecular dynamics with
Amber for the generation of transient cavities, FPocket for the
identification of such cavities [1], and computational docking
calculations and hot-spot predictions with pyDock to select the
best cavities for PPI modulation[2,3].
However, estimating the effects of a given single nucleotide
variant on a PPI is extremely challenging. We aim to apply this
methodology to known pathological variants from Humsavar
and ClinVar databases that affect PPIs. There are very few
experimental data for the effect on binding affinity of these
SNVs (according to SKEMPI database)[4,5]. Thus, in order
to estimate this effect, we initially mapped these structural
variants on protein-protein complex structures included in the
Protein-Protein Docking Benchmark 5 (formed by complexes
with available structure for the complex as well as for the
unbound components)[6]. The effect of these SNV on binding
affinity is predicted with mCSM[7], pyDock and FoldX[8].
Then, for the protein-protein interactions that are stabilized by
pathological variants, we will test on the unbound components
of the Docking Benchmark the identification of cavities suit-
able to find possible small molecule inhibitors.
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